Article info
PDFCancer genetics
Short report
Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma
- Correspondence to Dr Brigitte Bressac-de Paillerets, Département de Biopathologie, Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France; brigitte.bressac{at}gustaveroussy.fr
Citation
Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma
Publication history
- Received October 25, 2016
- Revised March 13, 2017
- Accepted March 14, 2017
- First published June 7, 2017.
Online issue publication
February 19, 2018
Article Versions
- Previous version (22 August 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.